The test is based on a 96 gene expression profile. Marc Rothenberg, MD, PhD, director of allergy and immunology at Cincinnati Children’s, is the senior author of the study.
The medical center has entered into an option agreement with molecular diagnostic company Diagnovus.
More Articles on Gastroenterology:
10 Statistics on GI/Endoscopy Revenue Per Care in Surgery Centers Across the Country
6 Recent GI-Driven Center Openings
8 Things to Know From ACG 2013 Annual Meeting
